Frost J J, Kaeser L
Alan Guttmacher Institute, New York, NY 10005, USA.
J Adolesc Health. 1995 May;16(5):367-72. doi: 10.1016/S1054-139X(94)00094-U.
The purpose of this article is to review the experiences of family planning clinic providers in making Norplant available to adolescents. We look specifically at the proportions of women receiving the implant from these providers who are teenagers, the policies adopted regarding implant education and whether or not parental consent is required for minors. Pricing policies and the implications of high method cost for teenagers are discussed. Finally, some of the policies adopted by state agencies related to adolescent use of the implant are reviewed.
The data come from two national surveys conducted by the Alan Guttmacher Institute (AGI). The first, a survey of family planning agencies, collected data from 616 family planning providers of clinic services (response rate 69%). The second surveyed the Medicaid, health and welfare agencies in all 51 jurisdictions about policies related to Norplant.
Over one-quarter of all contraceptive implants inserted by family planning agencies were provided to teenagers. Teenagers were routinely informed about the implant in about 85% of those clinics offering implant services. Few state agencies notify women about the implant. Twenty-three percent of all family planning agencies providing implant services report that parental consent must be obtained prior to implant insertion. The Medicaid program has paid for a majority of implant insertions at family planning agencies.
Teenagers who rely on publicly funded family planning clinics for contraceptive services face a variety of barriers in obtaining Norplant. High method cost, parental consent requirements and issues related to Medicaid eligibility are likely to deter some teenagers who might otherwise choose Norplant.
本文旨在回顾计划生育诊所提供者在向青少年提供诺普兰(皮下埋植避孕剂)方面的经验。我们特别关注从这些提供者处接受皮下埋植的女性中青少年的比例、所采用的关于皮下埋植教育的政策以及未成年人是否需要父母同意。讨论了定价政策以及方法成本高昂对青少年的影响。最后,回顾了一些州机构针对青少年使用皮下埋植所采取的政策。
数据来自艾伦·古特马赫研究所(AGI)进行的两项全国性调查。第一项是对计划生育机构的调查,收集了616家提供诊所服务的计划生育提供者的数据(回复率69%)。第二项调查了所有51个司法管辖区的医疗补助、卫生和福利机构关于与诺普兰相关的政策。
计划生育机构植入的所有避孕皮下埋植剂中,超过四分之一提供给了青少年。在约85%提供皮下埋植服务的诊所中,青少年会被常规告知皮下埋植剂的相关信息。很少有州机构通知女性有关皮下埋植剂的信息。提供皮下埋植服务的所有计划生育机构中有23%报告称,在植入皮下埋植剂之前必须获得父母同意。医疗补助计划为计划生育机构的大多数皮下埋植植入支付了费用。
依赖公共资助的计划生育诊所提供避孕服务的青少年在获取诺普兰方面面临各种障碍。方法成本高昂、父母同意要求以及与医疗补助资格相关的问题可能会阻碍一些原本可能选择诺普兰的青少年。